{
    "Trade/Device Name(s)": [
        "LZI Methadone Metabolite (EDDP) Enzyme Immunoassay",
        "LZI Methadone Metabolite (EDDP) (100 and 300) Calibrators"
    ],
    "Submitter Information": "Lin-Zhi International, Inc.",
    "510(k) Number": "K170416",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031797"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJR",
        "DLJ"
    ],
    "Summary Letter Date": "May 24, 2017",
    "Summary Letter Received Date": "May 25, 2017",
    "Submission Date": "February 9, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.3620",
        "21 CFR 862.3200"
    ],
    "Regulation Name(s)": [
        "Methadone test system",
        "Drug specific calibrators"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methadone Metabolite (EDDP)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Beckman Coulter AU480 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Spectrophotometric measurement"
    ],
    "Methodologies": [
        "Homogeneous enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for LZI Methadone Metabolite (EDDP) Enzyme Immunoassay and calibrators for detection of methadone metabolite in human urine on automated chemistry analyzers.",
    "Indications for Use Summary": "In vitro diagnostic test for qualitative and semi-quantitative determination of methadone metabolite (EDDP) in human urine at 100 ng/mL and 300 ng/mL cutoffs; intended for prescription use on automated clinical chemistry analyzers, as a preliminary screening with confirmation by GC/MS or LC/MS.",
    "fda_folder": "Toxicology"
}